TIFA: a signaling hub linking inflammation, innate immunity, and human disease
-
By
-
Yizhuo Fu
-
Yiting Zhan
-
Limei Li
-
Wenzhi Shen
-
Chunlei Guo
-
June 8, 2026
-
Clinical Scorecard: TIFA: A Central Signaling Node Connecting Inflammation, Innate Immunity, and Human Disease
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Individuals with chronic inflammation and blood cancers, as discussed in the source. |
| Care Setting | |
Key Highlights
- TIFA is a pivotal adaptor protein in innate immune signaling.
- Phosphorylation-dependent oligomerization of TIFA promotes higher-order signaling complexes.
- TIFA is involved in the activation of TRAF6 and downstream NF-κB signaling.
- The FHA domain of TIFA is crucial for recognizing phosphorylated motifs.
Guideline-Based Recommendations
Diagnosis
- Assess TIFA involvement in inflammatory and immune-related conditions.
Management
- Target TIFA pathways for therapeutic interventions in chronic inflammation and cancers.
Monitoring & Follow-up
- Monitor TIFA phosphorylation status as a potential biomarker for immune response.
Risks
Patient & Prescribing Data
Therapeutic strategies may involve modulation of TIFA signaling pathways, as indicated in the source.
Clinical Best Practices
- Utilize TIFA as a biomarker for inflammation and immune response.
- Investigate TIFA-targeted therapies in clinical trials.
Related Resources & Content
